Cat. #160943

RLUN014-2 Lung cancer organoid

Cat. #: 160943

Sub-type: Organoids

Unit size: 40-100 uL of cell pellet/vial, 1ml

Availability: 8-10 weeks

Organism: Human

Tissue: Lung

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Enquire or request a quote

Contributor

Inventor: Medical-Industrial Translational Research Center

Institute: Fukushima Medical University

Tool Details

Handling

Application Details

Documentation

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

Tool name: RLUN014-2 Lung cancer organoid
Alternate name: RLUN014-2, RLUN14-2, RLUN14, RLUN014
Cancer type: Lung cancer
Cancers detailed: Adenocarcinoma in situ;Lung;Papillary adenocarcinoma
Age y o : 77
Research fields: Cancer
Tool sub type: Organoids
Organism: Human
Tissue: Lung
Gender: Male
Growth properties: Suspension
Application: 3D cell culture, High-throughput screening
Description: A series of novel patient-derived organoids (PDOs) have been constructed from different tumor tissue types under the Fukushima Translational Research Project, designated as F-PDO. F-PDOs form large cell clusters with a morphology similar to the original tumor and can be cultured for more than six months. Our comparative histological and comprehensive gene expression analyses have shown that the characteristics of F-PDOs were similar to their source tumors, even after long-term growth in culture conditions
Biosafety level: 2

Handling

Format: Frozen
Passage number: 5
Growth medium: Cancer Cell Expansion Media plus (Fujifilm Wako Pure Chemical, Ltd.).
Temperature: 37°
Atmosphere: 5% CO2
Volume: 1 ml
Storage medium: CELLBANKER 2
Storage conditions: Liquid Nitrogen
Shipping conditions: Dry ice
Characterisation tests: Pathogen and stelility test; Comprehensive gene expression analysis; Cancer panel sequencing; Whole exome sequencing; Anticancer drug susceptibility testing
Mycoplasma free: Yes
Biosafety level: 2

Application Details

Application: 3D cell culture, High-throughput screening

Documentation

User manual
Brochure